Interstitial lung disease or diffuse parenchymal lung disease comprises a large group of more than 150 heterogeneous disorders. As a result, patients with these disorders are a difficult group to treat because many of the therapies are individualized to each patient. The Interstitial Lung Disease Clinic at Baylor University Medical Center, part of Baylor Scott & White Health, provides comprehensive care to patients with ILD.
Baylor University Medical Center is one of the major enrollment centers for two national clinical trials that could impact the field of lung transplantation. Both studies are looking at ways to treat early and established chronic rejection after lung transplant
The impact of frailty on outcomes for organ transplant recipients is gaining widespread attention in transplant programs around the world. In numerous studies, frailty has been associated with increased length of stay, increased hospitalizations, increased costs, and increased mortality.
Baylor Scott & White The Heart Hospital – Plano is playing a key role in developing a first-of-its-kind wound imaging device equipped with artificial intelligence to noninvasively evaluate wounds and chronically ischemic limbs. The WISCR (Wound Imaging System to Collect Clinical References) study is collecting wound images and data to further develop the DeepView Wound Imaging System device.
At the Vascular & Diabetic Foot Center at Baylor Scott & White The Heart Hospital – Plano, the focus is both to treat foot and ankle wounds and to prevent those wounds from occurring in the first place. As the only coordinated outpatient and inpatient program in North Texas with comprehensive care for the diabetic and vascular conditions affecting the foot, the Center takes a holistic approach to care.
